What is Alzheimer’s disease?
Alzheimer’s disease is a progressive neurodegenerative disorder and the most common cause of dementia, accounting for nearly 60-70% of all dementia cases worldwide. The World Health Organization estimates that more than 55 million people currently live with dementia, with Alzheimer’s disease representing the largest share. The condition is characterized by gradual cognitive decline, memory impairment, behavioral changes, and loss of functional independence.
Livingston and coauthor reported in the journal The Lancet that Alzheimer’s disease is not merely a disease of aging but a complex interplay of genetic, metabolic, vascular, inflammatory, and lifestyle-related factors that accumulate over decades before clinical symptoms appear. This long preclinical phase makes early recognition and preventive strategies critically important.
How Does Alzheimer’s Disease Occur?
Alzheimer’s pathology develops silently, often 15-25 years before symptoms become apparent. At a biological level, the disease is marked by the abnormal accumulation of two toxic proteins: amyloid-beta plaques outside neurons and tau neurofibrillary tangles inside neurons.
Selkoe and Hardy explain that amyloid-beta peptides aggregate due to impaired clearance mechanisms in the brain, triggering synaptic dysfunction and neuroinflammation. Over time, tau proteins become hyperphosphorylated, disrupting neuronal transport systems and leading to cell death.
The New England Journal of Medicine further reported that chronic neuroinflammation driven by activated microglia accelerates neuronal damage. In parallel, vascular dysfunction, insulin resistance in the brain (sometimes termed “type 3 diabetes”), mitochondrial dysfunction, and oxidative stress contribute to disease progression.
Genetic susceptibility also plays a role. According to Scheltens and coauthor, the APOE-ε4 allele significantly increases Alzheimer’s risk, particularly in late-onset cases, while rare mutations in APP, PSEN1, and PSEN2 genes are linked to early-onset familial Alzheimer’s disease. This study was reported in the Journal of the American Medical Association.
What Are the Symptoms of Alzheimer’s Disease?
Alzheimer’s symptoms typically begin subtly and worsen progressively. Early manifestations are often mistaken for normal aging, which delays diagnosis.
The Lancet Neurology reported that memory impairment, particularly difficulty forming new memories, is the most common early symptom. As the disease advances, additional cognitive domains become affected, including language, executive function, spatial awareness, and judgment.
1. Acute Symptoms of Alzheimer’s Disease
Acute symptoms refer to the initial, noticeable changes that prompt clinical concern.
The Journal of the American Medical Association Neurology describes early symptoms such as (i) episodic memory loss, (ii) difficulty recalling recent conversations, (iii) misplacing objects, and (iv) struggling with word retrieval. Individuals may show (v) reduced attention span, (vi) subtle personality changes, and (vii) difficulty performing complex tasks such as managing finances or planning work.
These symptoms are often accompanied by anxiety or mild depression, as individuals become aware of their cognitive decline.
2. Chronic Symptoms of Alzheimer’s Disease
As Alzheimer’s disease progresses, symptoms become more severe and disabling. Burns and Iliffe stated in The New England Journal of Medicine that chronic symptoms include profound memory loss, inability to recognize family members, disorientation to time and place, impaired speech, loss of motor coordination, and dependence on caregivers for daily activities. Behavioral and psychological symptoms such as agitation, aggression, hallucinations, paranoia, and sleep disturbances become increasingly common.
In late stages, patients may lose the ability to walk, swallow, or communicate, making them vulnerable to infections, malnutrition, and other complications.
Management and Treatment Strategies
Currently, there is no definitive cure, but evidence-based management strategies can slow progression, improve quality of life, and reduce caregiver burden.
According to the article published in The Lancet, Cummings and coauthors emphasize that Alzheimer’s management must be multidimensional, combining pharmacological treatment with lifestyle, environmental, and behavioral interventions.
Medication
Pharmacological treatment primarily targets neurotransmitter imbalances and, more recently, disease-modifying pathways.
The New England Journal of Medicine reports that cholinesterase inhibitors such as donepezil, rivastigmine, and galantamine improve cognitive symptoms by increasing acetylcholine availability. Memantine, an NMDA receptor antagonist, is used in moderate to severe stages to reduce glutamate-mediated neurotoxicity.
More recently, the Journal of the American Medical Association discussed monoclonal antibodies targeting amyloid-beta, such as lecanemab, which show modest slowing of cognitive decline in early Alzheimer’s disease, marking a shift toward disease-modifying therapies.
Lifestyle Changes
Strong evidence suggests that lifestyle interventions play a significant role. According to the article published in The Lancet Commission on Dementia Prevention, up to 40% of dementia cases may be preventable or delayed through lifestyle changes. Regular physical activity improves cerebral blood flow and neuroplasticity. Mediterranean-style diets rich in fruits, vegetables, whole grains, omega-3 fatty acids, and antioxidants reduce neuroinflammation and oxidative stress.
Adequate sleep, cognitive stimulation, social engagement, and stress management further support brain health.
Environmental Adaptation
Environmental modifications enhance safety, reduce confusion, and promote independence.
Clinics in Geriatric Medicine report that structured routines, adequate lighting, simplified layouts, visual cues, and reduced noise levels significantly decrease agitation and wandering behaviors in Alzheimer’s patients.
Behavioral Support
Behavioural interventions are essential for managing agitation, depression, anxiety, and sleep disturbances. An article published in The British Journal of Psychiatry highlights that non-pharmacological interventions such as cognitive behavioral therapy, music therapy, reminiscence therapy, and caregiver education reduce behavioral symptoms more safely than sedative medications.
Stages of Alzheimer’s Disease
Alzheimer’s disease is typically described in three to seven stages, depending on classification systems.
Alzheimer’s & Dementia Journal describes three broad stages: mild (early), moderate (middle), and severe (late). Early stages involve memory lapses and mild functional impairment. Middle stages are marked by significant cognitive decline, behavioral symptoms, and loss of independence. Late stages involve complete dependence, physical decline, and inability to communicate.
How Long Can a Person Live with Alzheimer’s Disease?
Life expectancy varies based on age, comorbidities, and quality of care. The New England Journal of Medicine emphasized that the average life expectancy after diagnosis ranges from 8 to 12 years, although some individuals may live up to 20 years. Early diagnosis and comprehensive care significantly influence outcomes.
When to Contact a Doctor?
Medical consultation is essential when memory problems interfere with daily life, behavioral changes become noticeable, or cognitive decline progresses rapidly.
The Journal of the American Medical Association emphasize that early evaluation allows differentiation between Alzheimer’s disease, mild cognitive impairment, depression, or reversible causes such as vitamin deficiencies or thyroid disorders.
Key Takeaway
Alzheimer’s disease is a complex, progressive neurological disorder with multifactorial causes. Although a cure remains elusive, advances in early diagnosis, disease-modifying therapies, and holistic management strategies offer meaningful improvements in quality of life.
Scientific evidence consistently shows that early intervention, lifestyle optimization, pharmacological treatment, environmental support, and caregiver education together form the cornerstone of effective Alzheimer’s disease management. As global research continues to evolve, integrating preventive strategies with emerging therapies remains the most promising path forward.
- Written By: Shabina Khan (Clinical Pharmacist)
- Medically Reviewed By: Dr Sachin (MD)